Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Cancer
|
June 1, 1989
Recovery of sperm production after chemotherapy for osteosarcoma
M L Meistrich, S P Chawla, M F Da Cunha, et al.
Radiology
|
March 1, 1989
Osteosarcoma: angiographic assessment of response to preoperative chemotherapy
C H Carrasco, C Charnsangavej, A K Raymond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1992
Preoperative chemotherapy for osteosarcoma with intravenous adriamycin and intra-arterial cis-platinum
R S Benjamin, S P Chawla, C H Carrasco, et al.
Seminars in Diagnostic Pathology
|
August 1, 1987
Osteosarcoma chemotherapy effect: a prognostic factor
A K Raymond, S P Chawla, C H Carrasco, et al.
British Journal of Cancer
|
September 12, 2013
Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials
A L Cesne, I Judson, R Maki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 1992
Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level
S Vadhan-Raj, H E Broxmeyer, W N Hittelman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 1, 2015
Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 trials
F Duffaud, S Sleijfer, S Litière, et al.
ESMO Open
|
December 31, 2025
A phase II study of the AKT inhibitor TAS-117 in patients with advanced solid tumors and germline PTEN mutations
J Ródon, H-T Arkenau, P Funchain, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 22, 2017
Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?
E Palmerini, N S Chawla, S Ferrari, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 12, 2025
A first-in-human, Phase 1/2a, open-label study of SQ3370, a first-in-class doxorubicin-based click chemistry therapeutic, in patients with advanced solid tumors
S P Chawla, E Abella, S Wieland, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Cancer
|
June 1, 1989
Recovery of sperm production after chemotherapy for osteosarcoma
M L Meistrich, S P Chawla, M F Da Cunha, et al.
Radiology
|
March 1, 1989
Osteosarcoma: angiographic assessment of response to preoperative chemotherapy
C H Carrasco, C Charnsangavej, A K Raymond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1992
Preoperative chemotherapy for osteosarcoma with intravenous adriamycin and intra-arterial cis-platinum
R S Benjamin, S P Chawla, C H Carrasco, et al.
Seminars in Diagnostic Pathology
|
August 1, 1987
Osteosarcoma chemotherapy effect: a prognostic factor
A K Raymond, S P Chawla, C H Carrasco, et al.
British Journal of Cancer
|
September 12, 2013
Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials
A L Cesne, I Judson, R Maki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 1992
Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level
S Vadhan-Raj, H E Broxmeyer, W N Hittelman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 1, 2015
Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 trials
F Duffaud, S Sleijfer, S Litière, et al.
ESMO Open
|
December 31, 2025
A phase II study of the AKT inhibitor TAS-117 in patients with advanced solid tumors and germline PTEN mutations
J Ródon, H-T Arkenau, P Funchain, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 22, 2017
Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?
E Palmerini, N S Chawla, S Ferrari, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 12, 2025
A first-in-human, Phase 1/2a, open-label study of SQ3370, a first-in-class doxorubicin-based click chemistry therapeutic, in patients with advanced solid tumors
S P Chawla, E Abella, S Wieland, et al.
Page
of 4